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Rhodococcus equi infection is increasing in regions with high HIV prevalence worldwide. The microbiological features and clini-
cal mimicry of tuberculosis infection pose diagnostic challenges in high-tuberculosis-incidence settings. We present two HIV-
associated cases of R. equi infection from Vietnam and discuss the unique diagnostic challenges in such settings.
CASE REPORTS
Case 1. A 27-year-old male was referred to the National Hospi-tal for Tropical Diseases in Hanoi, Vietnam, in 2011 with 2
months of fever, productive cough, and trouble breathing. He was
diagnosed with HIV in 2006 but had not started antiretroviral
therapy (ART). He worked as a nurse and had not had contact
with a farming environment or animals. The physical examina-
tion revealed a temperature of 39°C, labored breathing, and
lung crackles. Laboratory testing showed normal electrolytes,
transaminases, and creatinine but low hemoglobin (9.4 g/dl) (ref-
erence range, 14.5 to 15.7 g/dl) and elevated lactase dehydrogenase
(452 IU/liter) (reference range, 140 to 280 IU/liter). The CD4
count was 36 cells/l (reference range, 500 to 1,200 cells/l). Spu-
tum stains revealed Gram-positive bacilli and were negative for
acid-fast bacilli (AFB) and fungi. A chest X-ray showed a left upper
lobe consolidation with cavitary lesions (Fig. 1a) and a small pleu-
ral effusion. A thoracentesis was performed, and the pleural fluid
showed inflammatory exudates and Gram-positive coccobacilli
but no AFB or fungi. Blood culture on the day of admission
showed no growth. The patient did not improve after 1 week of
intravenous piperacillin-tazobactam at 3.375 g every 6 h and oral
metronidazole at 500 mg three times daily. On hospitalization day
10, the smooth mucoid salmon-pink appearance of the pleural
fluid culture raised suspicion for Rhodococcus equi (Fig. 1b). The
organism was identified by using API identification strips (bio-
Mérieux, Marcy l’Etoile, France) and was confirmed by 16S rRNA
sequencing. Subsequent blood culture (hospitalization day 21)
also grew R. equi. Susceptibility testing was performed by disk
diffusion method using Oxoid (Oxoid, Cheshire, United King-
dom) pills on sheep blood agar (Merck) using CLSI cutoffs for
Staphylococcus aureus. The isolate was susceptible to vancomycin,
ampicillin-clavulanate, rifampin, cefoxitin, cotrimoxazole, eryth-
romycin, gentamicin, levofloxacin, and ciprofloxacin and was re-
sistant to oxacillin, clindamycin, penicillin, and ampicillin. The
patient was started on oral rifampin at 450 mg daily, levofloxacin
at 750 mg daily, and erythromycin at 500 mg twice daily based on
susceptibility testing. His fever and respiratory symptoms gradu-
ally improved over 4 weeks of inpatient treatment. He was started
on ART and was discharged home after 6 weeks of hospitalization;
the patient was subsequently lost to follow-up.
Case 2. A 28-year-old male was admitted to the Hospital for
Tropical Diseases in Ho Chi Minh City, Vietnam, in 2012 with 2
months of fever, weight loss, and nonproductive cough. The pa-
tient had been working for 5 years in a greenhouse with frequent
manure exposure. The physical examination showed a tempera-
ture of 38°C, oral thrush, and enlarged cervical lymph nodes of 2
to 3 cm. Laboratory testing showed electrolytes, transaminases,
and creatinine levels within reference ranges but low hemoglobin
(7.3 g/dl). The results of three different enzyme-linked immu-
nosorbent assays (ELISAs) for HIV were positive, and the CD4
count was 61 cells/l. Multiple sputum stains for bacteria and AFB
were negative. A chest X-ray showed interstitial changes with a
small right pleural effusion. The patient was treated with intrave-
nous ceftriaxone at 2 g daily and oral cotrimoxazole at 160 mg
(trimethoprim)/800 mg (sulfamethoxazole) four times daily for
presumed bacteria and Pneumocystis jirovecii pneumonia for 1
week without clinical improvement. Blood culture on the day of
admission showed no growth. A chest computed tomography
showed mediastinal lymphadenopathy, numerous parenchymal
nodules, and a right pleural effusion (Fig. 2). A thoracentesis was
performed, and the pleural fluid showed inflammatory exudates
but was negative for Gram and Ziehl-Neelsen stains. Tuberculosis
was the leading diagnosis, and the patient was empirically started
on antituberculosis therapy with isoniazid at 300 mg daily, rifam-
pin at 450 mg daily, pyrazinamide at 1 g daily, and ethambutol at
800 mg daily. Pleural fluid culture on hospitalization day 7 grew
mucoid colonies of weakly acid-fast coccobacilli. The colonies
were identified as R. equi by using API identification strips. De-
spite the identification of R. equi, the treating clinicians refused to
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stop antituberculosis therapy. Upon discussions with infectious
disease specialists, levofloxacin at 750 mg daily was added to pro-
vide dual coverage for tuberculosis and R. equi. Fever and cough
resolved after 1 week. The patient completed a 6-month course of
therapy and remained well at month 18 of follow-up. His CD4
count rose to 465 cells/l on ART.
R. equi is increasingly recognized as a human pathogen, with
approximately 200 cases described in the literature (1). Eighty-five
percent ofR. equi infections in humans occur in immunocompro-
mised patients, with patients with HIV accounting for two-thirds
of cases (2). Approximately 50% of patients have some contact
with herbivores or their manure (3, 4). Mortality is 50% in HIV-
infected patients and is more than twice the mortality in HIV-
uninfected patients (3, 5). Most patients present with subacute
onset of pulmonary disease, chest radiographic abnormality, and
constitutional symptoms (1, 3). The majority of HIV-infected pa-
tients have concurrent bacteremia and may develop disease at
multiple distant sites (1, 5). Chest radiographs are abnormal in
95% of patients, and the most common radiographic findings are
cavitary lung lesions (75%) and pleural effusion (20%) (4, 11).
Diagnosis can be made via culture of biopsy specimens and all
bodily fluids (1).
On the basis of morphology, several microbiological features
of R. equi allow it to escape identification in a microbiology labo-
ratory. First, R. equi grows readily on nonselective medium; how-
ever its variable rod-to-coccus appearance can be mislabeled as
“mixed flora” on Gram-stained sputum. Early colonies have a
pleomorphic diphtheroid appearance, which can easily be dis-
missed as a contaminant. Further, the organism can be acid fast on
a Ziehl-Neelsen smear and be mistaken for a mycobacterium (1, 3,
5). R. equi was found to have the highest sequence homology with
Mycobacterium tuberculosis in a comparison with other bacterial
genera or species based on partial genome sequencing (6). The
close genetic distance may explain similarities in disease patho-
genesis, in particular the ability of R. equi to persist and multiply
inside macrophages (7) and to cause pyogranulomatous pneumo-
FIG 1 (a) Chest X-ray of patient 1 with arrows indicating several cavitary
lesions within the left upper lobe consolidation; (b) salmon-pink colonies after
7-day incubation of the pleural fluid, plated on Colombia blood agar.
FIG 2 Chest computed tomography of patient 2 showing a large pleural effu-
sion in the right lung. (a) Arrows indicate enlarged mediastinal lymph nodes;
(b) arrows indicate parenchymal nodules.
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nia in humans. On clinical grounds, human R. equi infection is
indistinguishable from tuberculosis and hence may be misdiag-
nosed in settings of high tuberculosis prevalence. Vietnam is
among those countries with the highest tuberculosis burden in the
world (8), with tuberculosis being the most common HIV-asso-
ciated diagnosis (9). Our patients presented with clinical features
characteristic of tuberculosis, and one patient was started on
antituberculosis treatment based on clinical suspicion. First-line
tuberculosis therapy exposes R. equi-infected patients to rifampin
monotherapy, which promotes development of resistance and
treatment failure (10). R. equi is inherently resistant to multiple
antibiotics (3, 12, 13), and long-term therapy with two to three
drugs is recommended particularly for immunocompromised pa-
tients (1). The duration of therapy depends upon the extent of
infection, clinical and radiographical resolution, and immune sta-
tus (1). Most experts recommend at least 6 months of therapy for
immunocompromised patients (1). Adding a fluoroquinolone to
the standard four-drug antituberculosis regimen provided anti-
microbial coverage for both R. equi and M. tuberculosis, which was
more acceptable to the clinicians caring for the patient, and in this
case resulted in good therapeutic outcome. In both patients, im-
mune reconstitution on ART was likely important to disease res-
olution.
Our case report highlights the challenge in diagnosing R. equi
infections in resource-limited settings with high tuberculosis and
HIV prevalence. Increased awareness of the disease and its diag-
nostic challenges may prevent misdiagnoses and may improve the
management of R. equi infections in these settings.
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